CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-09 | GUYER DAVID R Director | Grant or award · Stock Option (Right to Buy) | +11,000 | 22,000 | ||
| 2022-02-09 | DICICCO WENDY F Director | Option exercise | +2,500 | 4,400 | ||
| 2022-02-09 | DICICCO WENDY F Director | Option exercise · Restricted Stock Units | −2,500 | 0 | ||
| 2022-02-09 | DICICCO WENDY F Director | Grant or award · Restricted Stock Units | +3,000 | 3,000 | ||
| 2022-02-09 | DICICCO WENDY F Director | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2022-02-09 | ANDO GORAN Director | Option exercise | +2,750 | 4,900 | ||
| 2022-02-09 | ANDO GORAN Director | Grant or award · Restricted Stock Units | +3,250 | 3,250 | ||
| 2022-02-09 | ANDO GORAN Director | Option exercise · Restricted Stock Units | −2,750 | 0 | ||
| 2022-02-09 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-02-09 | Elston George Chief Financial Officer | Option exercise | +4,966 | 11,323 | ||
| 2022-02-09 | Elston George Chief Financial Officer | Shares withheld for taxes | −1,721 | $10.13 | $17K | 9,602 |
| 2022-02-09 | Elston George Chief Financial Officer | Option exercise · Restricted Stock Units | −4,966 | 9,934 | ||
| 2022-02-09 | Elston George Chief Financial Officer | Grant or award · Restricted Stock Units | +17,500 | 17,500 | ||
| 2022-02-09 | Elston George Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2022-02-09 | Duker Jay S. Chief Operating Officer | Option exercise | +4,966 | 10,623 | ||
| 2022-02-09 | Duker Jay S. Chief Operating Officer | Grant or award · Restricted Stock Units | +21,000 | 21,000 | ||
| 2022-02-09 | Duker Jay S. Chief Operating Officer | Option exercise · Restricted Stock Units | −4,966 | 9,934 | ||
| 2022-02-09 | Duker Jay S. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2022-02-09 | Paggiarino Dario A. Chief Medical Officer | Option exercise | +4,966 | 17,561 | ||
| 2022-02-09 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −1,721 | $10.13 | $17K | 15,840 |
Page 28 of 31 · 616 trades